Related Experiment Video
Updated: May 13, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Interactions between antiarrhythmic drugs and food
B Jáuregui-Garrido1, I Jáuregui-Lobera
1Department of Cardiology, Universitary Hospital Virgen del Rocío, Seville, Spain.
Nutricion Hospitalaria
|March 13, 2013
Summary
Food can alter how antiarrhythmic drugs work, affecting their effectiveness and side effects. Patients should be cautious with certain foods like grapefruit juice and consider timing fiber intake to optimize treatment.
Area of Science:
- Pharmacology
- Clinical Pharmacy
Background:
- Drug interactions can modify drug pharmacokinetics and pharmacodynamics.
- Antiarrhythmic drugs are susceptible to interactions with dietary factors, impacting efficacy and safety.
Purpose of the Study:
- To review existing literature on interactions between antiarrhythmic medications and food.
- To update knowledge on food-drug interactions relevant to antiarrhythmic therapy.
Main Methods:
- A literature search was conducted using PubMed.
- The search focused on identifying studies detailing food-antiarrhythmic drug interactions.
Main Results:
- Interactions were identified between antiarrhythmic drugs and general food components.
- Specific interactions were noted with grapefruit juice, dietary fiber, and medicinal plants.
Conclusions:
- Food, particularly grapefruit juice, dairy, and protein-rich diets, can affect antiarrhythmic drug bioavailability.
- Recommendations include avoiding grapefruit juice, separating fiber intake from medication, and assessing medicinal plant use.
Related Concept Videos
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...